Literature DB >> 17404711

Reevaluating the nicotine delivery kinetics hypothesis.

Reuven Dar1, Hanan Frenk.   

Abstract

RATIONALE: The view of smoking as an addiction to nicotine implies that nicotine is an addictive drug and a primary reinforcer. However, nicotine other than in tobacco does not appear to be very rewarding for smokers. This potential anomaly to the nicotine addiction thesis is resolved by the proposition that the reward associated with smoking depends on "high-nicotine boli." According to the nicotine delivery kinetics hypothesis, smoked nicotine reaches the brain in 5-10 s in high concentrations, which provide reinforcing "hits" of nicotine to the brain.
OBJECTIVES: Because of its essential role in the nicotine addiction thesis, this review set out to examine the current empirical basis of the nicotine delivery kinetics hypothesis.
MATERIALS AND METHODS: We reviewed studies that bear on two questions: First, does nicotine from cigarettes reach the brain significantly faster than from other nicotine delivery devices? Second, is there a relationship between delivery kinetics and any rewarding effects of nicotine?
RESULTS: There is little empirical support for the nicotine delivery kinetics hypothesis. Several studies found that arterial nicotine levels associated with smoking are much lower than predicted by the nicotine delivery kinetics thesis and not higher than with other nicotine delivery devices. More importantly, comparisons of nicotine delivery devices with varying speeds of delivery do not suggest any correlation between nicotine delivery profile and subjective reward.
CONCLUSIONS: This review indicates that the wide endorsement of the nicotine delivery kinetics hypothesis is unjustified. Critical research is required to resolve the anomalies within the nicotine addiction theory of smoking.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17404711     DOI: 10.1007/s00213-007-0768-1

Source DB:  PubMed          Journal:  Psychopharmacology (Berl)        ISSN: 0033-3158            Impact factor:   4.415


  35 in total

1.  Arterial nicotine kinetics during cigarette smoking and intravenous nicotine administration: implications for addiction.

Authors:  J E Rose; F M Behm; E C Westman; R E Coleman
Journal:  Drug Alcohol Depend       Date:  1999-09-01       Impact factor: 4.492

2.  Pharmacokinetics and pharmacodynamics of moist snuff in humans.

Authors:  R V Fant; J E Henningfield; R A Nelson; W B Pickworth
Journal:  Tob Control       Date:  1999       Impact factor: 7.552

3.  Dissociating nicotine and nonnicotine components of cigarette smoking.

Authors:  J E Rose; F M Behm; E C Westman; M Johnson
Journal:  Pharmacol Biochem Behav       Date:  2000-09       Impact factor: 3.533

4.  Craving to smoke in orthodox Jewish smokers who abstain on the Sabbath: a comparison to a baseline and a forced abstinence workday.

Authors:  Reuven Dar; Florencia Stronguin; Roni Marouani; Meir Krupsky; Hanan Frenk
Journal:  Psychopharmacology (Berl)       Date:  2005-10-20       Impact factor: 4.530

Review 5.  Nicotine and nonnicotine factors in cigarette addiction.

Authors:  Jed E Rose
Journal:  Psychopharmacology (Berl)       Date:  2005-12-16       Impact factor: 4.530

6.  Reactivity to instructed smoking availability and environmental cues: evidence with urge and reaction time.

Authors:  L M Juliano; T H Brandon
Journal:  Exp Clin Psychopharmacol       Date:  1998-02       Impact factor: 3.157

7.  Effect of intravenous injection speed on responses to cocaine and hydromorphone in humans.

Authors:  M E Abreu; G E Bigelow; L Fleisher; S L Walsh
Journal:  Psychopharmacology (Berl)       Date:  2001-02       Impact factor: 4.530

8.  Pharmacologic and sensorimotor components of satiation in cigarette smoking.

Authors:  Jed E Rose; Frederique M Behm; Eric C Westman; James E Bates; Al Salley
Journal:  Pharmacol Biochem Behav       Date:  2003-09       Impact factor: 3.533

Review 9.  Reducing the addictiveness of cigarettes. Council on Scientific Affairs, American Medical Association.

Authors:  J E Henningfield; N L Benowitz; J Slade; T P Houston; R M Davis; S D Deitchman
Journal:  Tob Control       Date:  1998       Impact factor: 7.552

10.  Nicotine absorption and cardiovascular effects with smokeless tobacco use: comparison with cigarettes and nicotine gum.

Authors:  N L Benowitz; H Porchet; L Sheiner; P Jacob
Journal:  Clin Pharmacol Ther       Date:  1988-07       Impact factor: 6.875

View more
  5 in total

1.  Nicotine reinforcement in never-smokers.

Authors:  Angela N Duke; Matthew W Johnson; Chad J Reissig; Roland R Griffiths
Journal:  Psychopharmacology (Berl)       Date:  2015-09-08       Impact factor: 4.530

2.  How Intravenous Nicotine Administration in Smokers Can Inform Tobacco Regulatory Science.

Authors:  Kevin P Jensen; Elise E DeVito; Mehmet Sofuoglu
Journal:  Tob Regul Sci       Date:  2016-10-01

3.  Differential effects of nicotine delivery rate on subjective drug effects, urges to smoke, heart rate and blood pressure in tobacco smokers.

Authors:  Kevin P Jensen; Gerald Valentine; Ralitza Gueorguieva; Mehmet Sofuoglu
Journal:  Psychopharmacology (Berl)       Date:  2020-01-29       Impact factor: 4.530

4.  Thwarting science by protecting the received wisdom on tobacco addiction from the scientific method.

Authors:  Joseph R Difranza
Journal:  Harm Reduct J       Date:  2010-11-04

5.  Hooked on the nicotine addiction thesis: a response to DiFranza.

Authors:  Reuven Dar; Hanan Frenk
Journal:  Harm Reduct J       Date:  2013-11-18
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.